Data from Phase 1b/2 trial of evorpacept + zanidatamab presented at ESMO Breast Cancer 2026 showed all patients with confirmed HER2-positive ...

Data from Phase 1b/2 trial presented at ESMO Breast Cancer 2026 further validate a biomarker-driven development strategy for ...

Company Will Discuss Data and Report First Quarter 2026 Financial Results on May 8 - SOUTH SAN FRANCISCO, Calif., April 30, 2026 (GLOBE ...

Finding the right breast pump has been a game-changer in my breastfeeding journey. The Momcozy M9 hands-free breast pump has ...

Between December 2024 and February 2025, 10 newborns with hypoxic-ischemic brain injury were treated with breast milk ...

Mechanistic insights on how NRG4 suppresses obesity-driven breast cancer metastasis Breast cancer remains a leading cause of ...

Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical ...

Researchers from Drexel University's College of Medicine have identified a critical metabolic vulnerability in breast cancer that has spread to the brain, offering a promising new therapeutic target ...

Influencer Emma Adams has died at age 44 after documenting her life with breast cancer following her diagnosis in 2023 The ...